View more on these topics

Axa Wealth poaches Nucleus COO

Andrew Smith Axa Elevate
Andrew Smith

Axa Wealth has appointed Nucleus chief operating officer Andrew Smith to act as chief operating officer for Elevate.

Smith will join Elevate’s senior management on 3 September and will report to Axa Wealth chief executive Mike Kellard.

Smith joined Nucleus in 2006 when the platform launched and was responsible for the platform’s design and build. 

Axa Wealth chief executive Mike Kellard says: “The appointment of Andrew Smith is a demonstration of our commitment to both attract and develop the best people in the industry. Securing Andrew will help further develop the strength of our overall adviser offer ahead of the introduction of the RDR.”

Smith says: “I recognise Axa Wealth as being a leading platform provider in the industry today, and one whose ambitious strategy promises to further enhance its presence in what is becoming an increasingly competitive market. I look forward to playing an integral part in bringing that strategy to fruition.

“I am extremely proud of what we have achieved at Nucleus over the last six years. Having played a significant role in the growth and development of the business to date, I now feel the time is right to find a new challenge and I believe that is at Axa.”

Nucleus chief executive David Ferguson says: “I have known Andy for over 30 years and worked with him for the last six. He is a hugely talented individual who has played an important role in helping Nucleus get to where it is today. As one of the best problem solvers in the platform space I can totally understand why a business like Axa would be keen to have him on board. While we are naturally sad to see him go he leaves with our gratitude and thanks.”

Nucleus is currently recruiting for Smith’s replacement.

Newsletter

News and expert analysis straight to your inbox

Sign up

Comments

There are 4 comments at the moment, we would love to hear your opinion too.

  1. Who? Elevate? Never heard of them?

  2. Why move from an entrepreneurial little company where you are a big fish in a small pond to exactly the opposite? Hmm.

  3. Smith says: “I recognise Axa Wealth as being a leading platform provider in the industry today”

    What about Nucleus then? Why does he feel it is the right time to go? This does not send a good message out to the industry and these comments are a slap in the face for David and the team!

  4. Can Elevate opreate with reduced cost? especially Testing…….

Leave a comment